Humacyte rustles up $12 million and a new chief executive

September 9, 2010 by MedCity News

Regenerative medicine firm Humacyte Inc. nets pharma vet Carrie Cox for CEO and a $12 million investment.

MedCity News logo

Duke University spin-off Humacyte Inc. landed a $12 million investment and pharmaceutical industry veteran Carrie Cox for CEO.

The Durham, N.C.-based regenerative medicine company recently raised $12 million from a single investor through a debt offering, according to an amended filing with the Securities & Exchange Commission. Another amended filing shows the company raised $7 million in debt about a year ago.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.